Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMVF | ISIN: CA86102Q1081 | Ticker-Symbol: P0G
München
21.01.25
08:00 Uhr
0,005 Euro
0,000
0,00 %
1-Jahres-Chart
STOCK TREND CAPITAL INC Chart 1 Jahr
5-Tage-Chart
STOCK TREND CAPITAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0020,00921.01.
ACCESS Newswire
675 Leser
Artikel bewerten:
(2)

Stock Trend Capital Inc.: Stock Trend Capital Provides Update on Syntheia Investment

Finanznachrichten News

Highlights

  • Syntheia announces receipt of conditional approval for listing on the Canadian Securities Exchange

  • Final approval and commencement of trading is anticipated to occur in the second half of September 2024.

VANCOUVER, BC / ACCESSWIRE / August 22, 2024 / Stock Trend Capital Inc. (CSE:PUMP)(FRA:WCF)(OTC PINK:STOCF) (the "Company" or "Stock Trend") is pleased to provide an update on its investment in Metaworld Corporation (dba Syntheia) ("Syntheia"), a Canadian-based AI technology company operating, developing, and commercializing conversational AI technology.

On August 21, 2024, Syntheia issued a news release announcing that the company has received conditional approval to list the common shares of Veta Resources Inc. ("Veta") following the completion of the amalgamation transaction between Veta and Syntheia on the Canadian Securities Exchange ("CSE"). The complete Syntheia press release can be accessed on their website at www.syntheia.ai

In a statement, Anthony Durkacz, CEO of Stock Trend Capital, congratulated the Syntheia team on its success. "Congratulations on achieving a significant milestone that reflects the hard work and dedication of your team and we look forward to seeing your continued growth in the future".

About Stock Trend

Stock Trend Capital Inc. is an investment issuer primarily focused on the Artificial Intelligence (AI) and Canadian cannabis industries. The issuer intends to focus on investing in private and public entities with strong intellectual property, exceptional management and high growth potential that may be strategically positioned in the market.

On behalf of the Board of Directors of
STOCK TREND CAPITAL INC.

FOR FURTHER INFORMATION, PLEASE CONTACT:
Anthony Durkacz
CEO, Director
Telephone: (416) 720-4360
Email: anthony@stocktrend.com

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward- looking statements.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward, looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no insurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

The CSE has not reviewed, approved, or disapproved the content of this press release.

SOURCE: Stock Trend Capital Inc.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.